ea0070aep658 | Pituitary and Neuroendocrinology | ECE2020
Remon Pablo
, Venegas-Moreno Eva
, Deniz-Garcia Alejandro
, Millan Raquel
, Dios-Fuentes Elena
, Martin Natalia
, Rico Maria C
, Madrazo Ainara
, Romero-Gómez Manuel
, Soto-Moreno Alfonso
Introduction: The prevalence and comorbidities of NAFLD in CD are unknown. There is only one study wich set the prevalence of NAFLD by CT images in 20%1.Objectives: Describe the prevalence of NAFLD and fibrosis in CD and analize predictive biomarkers of NAFLDMethods: Transversal descriptive study. 31 patients with CD; 11 active, 20 cured. Women 24 (77%), men 7 (23%). 54 years mean age. NAFLD was valorated by Hepatic Stea...